Serum immunoglobulin A (IgA) concentrations were determined in 12 600 adult Swedish twins, applying a high-throughput reverse-phase protein microarray technique. The prevalence of IgA deficiency (IgAD) was found to be 1:241 in monozygotic (MZ) twins and 1:198 in dizygotic (DZ) twins. Hence, the prevalence in twins is markedly elevated as compared with the normal Swedish adult population (1:600). The twins did not show a difference in the frequency of HLA haplotypes in comparison with almost 40 000 healthy Swedish controls. As expected, the risk-conveying HLA alleles A*01, B*08 and DRB1*01 were overrepresented among the IgAD twins and were also associated with significantly lower mean serum IgA concentrations in the twin cohort. In contrast, significantly higher mean IgA concentrations were found among individuals carrying the protective HLA alleles B*07 and DRB1*15. Exome sequencing data from two MZ twin pairs discordant for the deficiency showed no differences between the siblings. Model fitting analyses derived a heritability of 35% and indicate that genetic influences are modestly important for IgAD. The probandwise concordance rates for IgAD were found to be 31% for MZ and 13% for DZ twins.
INTRODUCTION
Immunoglobulin A (IgA) is the most abundantly produced Ig in the human body and accounts for at least 70% of all produced Igs. 1 It protects from invading pathogens at mucosal sites including the gastrointestinal and respiratory tracts. 2, 3 In the vast majority of individuals, serum IgA concentrations are highly correlated with mucosal IgA concentrations. 4 Selective IgA deficiency (IgAD) is defined as serum IgA concentrations ⩽ 0.07 g l − 1 with normal levels of serum IgG and IgM. 5 It is the most common primary immunodeficiency in humans with a frequency ranging from 1:143 in Saudi Arabia 6 to 1:18 500 in Japan. 7 In Sweden, the prevalence of IgAD in adults is 1:600. 4 Recent studies show that IgA-deficient individuals have a significantly poorer physical health 8 and an increased risk of mortality. 9 Twins provide a unique possibility to study the complex interplay of genes and environment in propensity to disease (for review see Boomsma et al. 10 ). To our knowledge, there are only six references on serum IgA concentrations in twins. Two studies quantified and compared serum IgA concentrations in monozygotic (MZ) and dizygotic (DZ) twins. 11, 12 The first study suggests a genetic influence on serum IgA concentrations based on a higher intrapair similarity for MZ twins. 11 The second study shows that IgA concentrations are under both genetic and environmental influences. 12 Three studies are case reports on pairs of MZ twins discordant for IgAD. [13] [14] [15] The most recent paper focused on susceptibility genes for Ig deficiencies in MZ twins discordant for type 1 diabetes (T1D). 16 They showed that pairwise concordance for IgA concentrations is 50% among MZ twins discordant for T1D, and hence markedly higher as compared with random paired controls.
Twin studies investigating disease etiology usually focus on heritability estimates and concordance rates for MZ and DZ twins. Hence, numbers on disease rates for twins in comparison with the population are rare. To the best of our knowledge, the postchildhood rates of different diseases were similar in twins and adult population rates.
Studies on familial resemblance suggest that IgA concentrations are under the control of a single gene; 17, 18 however, recent genome-wide association studies suggest association with several genes. A genome-wide association study on Chinese men reported tumor necrosis factor (ligand) superfamily, member 13 (TNFSF13) to have an influence on serum IgA concentrations. 19 Recently, we reported that two single-nucleotide polymorphisms, one upstream of the gene SAM and SH3 domain containing 1 (SASH1) and the other downstream of the CD30 ligand (CD30L) encoding gene, are associated with serum IgA concentrations. 20 To investigate the genetic basis of IgAD among twins, we screened more than 3000 MZ and 9000 DZ twins for serum IgA concentrations using a high-throughput reverse-phase protein microarray. 21 The technique allows for screening of a large number of serum samples for a target protein in a single experiment. 21 The IgA concentrations obtained by this approach have been previously published in the genome-wide association studies study mentioned above. 20 The purpose of this study was to characterize the occurrence and concordance of IgAD in MZ and DZ twins and to identify MZ twin pairs discordant for IgAD for further functional studies.
RESULTS
Correlation between reverse-phase protein microarray and ELISA For 384 MZ twins, IgA concentrations were measured by both enzyme-linked immunosorbent assay (ELISA) and serum array. The correlation between the two measurements was 0.57. The difference between the measurements was found to be higher for samples with low and very low concentrations ( Figure 1 ). In case of discrepancy in the measurements, the array data were used. Compared with ELISA, the serum array excels in an increased precision for low and very low concentrations. Furthermore, its enhanced linear range makes sample dilutions unnecessary.
Distribution of IgA concentration
The mean IgA concentration was 2.38 g l − 1 (s.d. 1.03) for MZ twins and 2.56 g l − 1 (s.d. 1.17) for DZ twins. The difference in the mean concentration was found to be significant (t = − 7.8, d.f. = 12 611, P-value = 9.9e − 15) with an extremely small effect size (η 2 = 0.0047). The sex-stratified means were 2.53 g l − 1 for male MZ twins, 2.26 g l − 1 for female MZ twins, 2.71 g l − 1 for male DZ twins and 2.43 g l − 1 for female DZ twins. The mean IgA concentrations of male and female twins were found to be significantly different by one-way analysis of variance (P-value = 1.429e − 43).
The samples were obtained between 2004 and 2008 and at different times of the year, but no significant difference in the concentration was observed in a time-of-sampling-dependent manner (data not shown).
Intrapair correlations
The IgA concentrations of MZ twins are more similar (r = 0.44) as compared with concentrations in DZ twin pairs (r = 0.26), and indicate a heritability of 44% pooled across sexes ( Figure 2 ). The intrapair correlations are 0.36 for male MZ pairs, 0.31 for DZ male pairs, 0.49 for MZ female pairs, 0.26 for DZ female pairs and 0.21 for opposite sex DZ pairs. Sex-specific heritability estimates for the IgA concentrations of this cohort have been published previously. 20 Influence of HLA alleles on IgA concentrations A comparison of HLA haplotypes of the study population, based on imputation of HLA types from genome-wide association studies data, with almost 40 000 individuals from the National Swedish Bone Marrow Donor Registry (Tobias Registret; http:// www.tobiasregistret.se) shows no difference in the frequency of HLA alleles in the twin cohort compared with a national sample (data not shown).
Analysis of variance was performed to investigate the influence of individual HLA alleles on the IgA concentration ( Figure 3 ). For MZ twins, IgA concentrations from one twin per twin pair were used for the analysis. For DZ twins, IgA concentrations from (if available) both twins of the pair were used. The HLA alleles A*01, B*08, B*13, B*14, DQB1*05, DRB1*01 and DRB1*07 were associated with IgAD, [22] [23] [24] [25] [26] [27] [28] whereas the HLA alleles B*07 and DRB1*15 conveyed protection against the disease. 22 Individuals with the HLA alleles A*01, B*08, B*14, DRB1*01, DRB1*03 and DQB1*05 (including those with IgAD) were found to have a significantly lower mean IgA concentration. Individuals carrying the HLA alleles B*07, DRB1*15 and DQB1*06 were found to have an increased mean IgA concentration. No significant difference was found between individuals with or without the HLA alleles B*13, DQB1*02 and DRB1*07 alleles. The associations remained significant even after correction for multiple testing with Benjamini and Hochberg correction. 29 The HLA types of IgAD twins were similar as compared with IgAD non-twins (data not shown). Furthermore, the HLA types of the MZ IgAD twins did not differ significantly from the DZ twins.
IgA deficiency Initially, 71 samples (16 MZ and 55 DZ) showed very low, albeit not deficient, IgA concentrations (⩽0.12 g l − 1 ) using the reverse-phase protein microarray. All the 71 samples were subsequently remeasured by ELISA. For six of the potentially IgA-deficient samples, IgA concentrations between 0.08 and 0.12 g l − 1 were found. For three potentially IgAD MZ twins, conflicting results were obtained from the serum array and the ELISA. Two appeared deficient in the microarray but not in ELISA ( o0.07 vs 0.12 g l − 1 and o 0.07 vs 0.18 g l − 1 ). The third twin was deficient in ELISA but showed a low concentration in the serum array (o 0.07 vs 0.15 g l − 1 ).
IgAD could be confirmed by ELISA in 62 twins (14 of 3130 MZ and 48 of 9483 DZ). After obtaining fresh blood samples for some of the individuals, the number of IgAD MZ twins was reduced to 13 (Table 1) , leading to a frequency of 1:241 for MZ and 1:198 for DZ twins. The frequencies in MZs and DZs did not differ significantly (Fisher's exact test, P-value = 0.656). The number of IgAD males (1:185) and females (1:229) did not differ significantly (Fisher's exact test, P-value = 0.441).
The intrapair correlation was 0.78 for MZ (2 concordant pairs and 9 discordant pairs) and 0.59 for DZ twins (2 concordant pairs, 26 discordant pairs). Model fitting analyses using the structural equation modeling program Mx 30 derived a heritability of 35% and indicates that the genetic influence is of modest importance in IgAD.
Resampling of IgAD MZ twins
A transient form of IgAD can be induced by anti-inflammatory and immunosuppressive drugs. To confirm the deficiency status of the MZ twin pairs discordant for IgAD, the measurements by serum array and ELISA should be confirmed with fresh serum samples. We therefore invited the 3 living twin pairs from the 10 MZ twin pairs discordant for IgAD to provide a fresh sample. Sera were sent to the routine diagnostic laboratory at the Karolinska University Hospital (Stockholm, Sweden) for IgA measurement by nephelometry. To confirm the zygosity status, HLA typing was performed For one twin pair, monozygosity as well as discordancy for IgAD could be confirmed (Supplementary Table 2 ). The IgAD noted initially in one of the remaining two twin pairs was found to have reverted and showed a normal IgA concentration, suggesting a transient, potentially drug-induced, IgAD. The third twin pair was found to be concordant for IgAD.
The patient records from all twins from the Stockholm region who could not provide a fresh sample because of the death of one of the twins were evaluated for previous Ig measurements or for indications potentially related to IgAD. No entries were found for any of the twins. Furthermore, information on self-reported drugs did not suggest a drug-induced form of IgAD for these twins.
Exome sequencing
Exome sequencing was carried out on two MZ twin pairs discordant for IgAD. No mutations or structural variants were found in comparison with the IgA-sufficient twin (data not shown).
DISCUSSION
The prevalence of IgAD among 12 600 adult Swedish twins was found to be 1:207, and hence markedly increased as compared with the normal Swedish population. As IgAD is known to be strongly associated with genes inside 22 and outside 23 the major histocompatibility complex region, one might speculate about the contribution of genetic factors to the increased prevalence in twins. Three major haplotypes have been shown to be associated with IgAD, HLA-B*08, DRB1*03, DQB1*02, 24, 25 HLA-DRB1*07, DQB1*02 and HLA-DRB1*01, DQB1*05. 26, 27, 23, 28, 22 As the disease prevalence is higher in twins, we investigated the frequency of these haplotypes, but the frequency of the predisposing haplotypes were similar to those of the almost 40 000 individuals in the National Swedish Bone Marrow Donor Registry. The IgAD predisposing haplotypes were similar in twins and non-twin patients with IgAD, suggesting that their etiology is similar. We thus exclude a difference in HLA as a potential cause of the increased frequency of IgAD in twins compared with the normal adult Swedish population. In addition to the haplotypes, the HLA alleles A*01, B*13 and B*14 are also known to be associated with the disorder, 22 whereas the HLA alleles B*07 and DRB1*15 are known to confer protection against IgAD. 22 Interestingly, we found that individuals with the HLA risk alleles A*01, B*08, B*14, DRB1*01, DRB1*03 and DQB1*05 have a significantly lower mean serum IgA concentration. The protective HLA alleles B*07, DRB1*15 and DQB1*06, on the other hand, were associated with a significantly increased mean serum IgA concentration. We believe that this is the first study that shows that these alleles were found to not only convey a risk/protection for the disorder but also to influence 'normal' serum IgA concentrations.
Exome sequencing was performed on two MZ twin pairs discordant for IgAD to exclude differences in the coding DNA sequence as a potential cause for the increased frequency. Even though this is a small sample size, no differences in DNA sequence or structural variants were found between the twins, suggesting an epigenetic cause for IgAD in one of the twins in the discordant pairs.
In conclusion, no underlying genetic difference was found that could explain the increase in the prevalence of the disorder as compared with the healthy population.
There is a multiplicity of studies investigating the prevalence of IgAD worldwide (Supplementary Table 1 ), most of which are based on the screening of blood donors. For some countries, several studies exist, that is, there are three studies on serum IgA concentrations in blood donors in Canada [31] [32] [33] [34] [35] and the reported prevalence for IgAD ranges from 1:219 35 to 1:1291. 31 Some studies, using partially different techniques, sample types and cutoffs, show a range from 1:328 36 to 1:3024 37 for the prevalence of IgAD in the United States of America. Given the differences in quantification methods and cutoffs used to define IgAD, the different prevalences could potentially suggest a difference in the frequency of donations by IgAD-and IgA-sufficient donors, making it difficult to compare individual studies.
For Sweden, information on the prevalence in the normal population can be considered robust. Two studies serve as references. The first study is a screening of 70 000 Swedish blood donors, where 1:600 individuals were found to have IgAD. 7 The second study is a population-based study from the 1960s, which included 6995 individuals aged 25 years or older, where the prevalence was found to be 1:700. 38 Twins provide an excellent opportunity to study the interaction between genes and the environment in disease development. The difference in genetic similarity between MZ and DZ twins enables researchers to draw conclusions about the genetic contribution to diseases. In our case, the increase in disease prevalence compared with the healthy population and a heritability of 35% for IgAD suggests a moderate genetic influence and emphasizes the importance of environmental factors for the development of the disorder.
There is only one twin study on the concordance rate for IgAD. 16 MZ twins discordant for T1D were analyzed for Ig concentrations, and serum IgA concentrations were found to be more closely correlated in the twins than in random paired controls. The prevalence of IgAD among patients with T1D is known to be higher compared with the general population. 39, 40 The authors reported a pairwise concordance rate of 50% for IgAD among four MZ twin pairs discordant for T1D, suggesting an incomplete penetrance for certain MHC-determined Ig deficiencies. 16 One study suggested an increased predisposition to type 2 diabetes (T2D) in twins, and others emphasize the importance of the mode of delivery for T1D, both of which (T1D and T2D) may result in a higher rate of IgAD. Poulsen et al. found evidence that twin status is associated with abdominal obesity, insulin resistance and increased prevalence of T2D. 41 However, another study on a larger cohort (n = 77 885 twins) shows that twins do not differ from singletons in the prevalence of T2D. 42 Delivery by cesarean section was previously found to be associated with an increased risk of T1D in children. 43, 44 The authors suggested that the gut microbiota accounts for the increased risk. 43 In the United States, up to 75% of all twins are born by cesarean section, 45 while the overall rate for cesarean sections is 33%. 46 As twins are much more likely to be born by cesarean section, they might have an increased risk for T1D. However, in a population-based study, the association between cesarean section and T1D disappeared when siblings were compared, suggesting that the association between cesarean section and T1D may be due to family-related factors. 47 All of the twins included in this study were born before cesarean sections became common Sweden, and hence we do not believe that mode of delivery would contribute to an increased rate of T1D as a potential explanation for the prevalence of IgAD in this material. DZ twinning is reported to increase by maternal age 48 and a higher parental age is known to increase the risk for T1D, 49, 50 suggesting an increased frequency of T1D in DZ twins. However, even if DZ twinning varies by maternal age, this would not explain why MZ and DZ rates of IgAD are relatively similar.
To the best of our knowledge, postchildhood disease rates were similar in twins and adult populations. However, we noted a markedly higher disease rate for IgAD in adult twins. One could speculate about the contribution of a shared prenatal environment, or non-HLA genetic differences, to the higher prevalence. Epigenetic mechanisms are known to be involved in other autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis and T1D (for review see Quintero-Ronderos and Montoya-Ortiz 51 and Greer and McCombe 52 ). We thus suggest the exposure to as yet unknown environmental trigger as being crucial for the development of IgAD.
MATERIALS AND METHODS Samples
Samples were obtained from the TwinGene project, a population-based study of Swedish twins of European ancestry born between 1911 and 1958, which included collection of serum and DNA between 2004 and 2008. 53 For the participants to be included in the study, both twins within a pair had to be alive and have participated in a previous telephone interview. 54 Serum samples from 12 613 individuals were included in this study. For 2589 samples, the twin partner did not provide a sample. For most of the twins (82%) zygosity information is based on self-reported childhood resemblance. To validate the zygosity classification, 13 DNA markers were used to determine zygosity for 199 random adult pairs and it was found correct in 99% of the pairs. 54 In total, 3130 MZ twins and 9483 DZ twins were included in this study. Informed consent was obtained from all participants. The study was approved by the ethics board at Karolinska Institutet (Stockholm, Sweden).
Reverse-phase protein microarray
IgA concentration was measured by a reverse-phase protein microarray as described previously. 20 In brief, diluted serum samples were spotted on epoxy-coated microarray slides (Corning, New York, NY, USA) using the 2470 Arrayer Microarray Printing Platform (Aushon Biosystems, Billerica, MA, USA). For detection of IgA, rabbit anti-human IgA (DakoCytomation, Glostrup, Denmark) and Alexa Fluor 555-conjugated goat anti-rabbit antibodies (Molecular Probes, Eugene, OR, USA) were used and diluted 1:100 000 and 1:60 000, respectively. Images were generated with a highresolution microarray scanner (Agilent Technologies, Santa Clara, CA, USA) and analyzed using GenePix Pro 7 (Molecular Devices, Sunnyvale, CA, USA).
ELISA
In addition to the serum array measurement, all MZ twins (n = 3130) were also screened for serum IgA concentrations by an ELISA using rabbit antihuman IgA antibodies (DakoCytomation) diluted 1:4000 in carbonate/ bicarbonate buffer and polyclonal, α-chain-specific, AP-conjugated rabbit anti-human IgA (Jackson Immunoresearch, West Grove, PA, USA) diluted 1:2000 in PBST. The serum samples were diluted 1:5000 in PBST.
Random samples from 384 MZ twins as well as all samples with an IgA concentration o0.12 g l − 1 in the array or a low concentration in ELISA (n = 71) were selected for an additional ELISA measurement. An arbitrary cutoff of 0.12 g l − 1 was chosen to ensure inclusion of all potentially deficient samples and the samples were diluted 1:5000, 1:10 000 and 1:20 000 in PBST. Samples with an IgA concentration ⩽ 0.07 g l − 1 were considered IgA deficient.
HLA typing
HLA types were imputed from genotype data 20 using HLA*IMP. [55] [56] [57] MZ twin pairs found to be discordant for IgAD were also genotyped at the HLA-B, DRB1 and DQB1 loci using PCR-single-strand polymorphism. 58 Standard procedures were used for DNA preparation followed by wholegenome amplification according to instructions from the manufacturer (GenomePhi V2 DNA Amplification Kit; GE Healthcare, Little Chalfont, UK). The kits used for HLA typing in this study included the HLA-B low resolution (lot. no. 98 M) and the HLA DQ-DR SSP Combi Tray (lot. no. 11 M) (Olerup SSP AB, Stockholm, Sweden).
Exome sequencing
Exome sequencing was performed on two MZ twin pairs discordant for IgAD to exclude differences in the DNA sequence as a potential cause for the increased frequency. One of the pairs was identified in an earlier internal study. The exome sequencing was carried out as described previously. 59 Briefly, captured libraries were generated by ligationmediated PCR. The fragments were hybridized using the Agilent SureSelect Human All Exon 50 Mb Kit (Agilent Technologies Incorporated). Each captured library was then loaded on a Hiseq2000 Illumina sequencer (Illumina Incorporated, San Diego, CA, USA) according to the protocol of the manufacturer and high-throughput sequencing was performed to acquire the desired average sequencing depth. [31] [32] [33] 6, 37, 
